Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo (Nasdaq: NUVO) -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (64)	10/22/1999 6:51:00 PM
From: Pierre Borczuk	Read Replies (1) \| Respond to of 286

Wow CIST ... glad i am not trapped in that one! Thursday September 30, 1:06 pm Eastern Time Cistron '99 loss slims, mulls liquidation Anyway ..looking at (and superficially) CIST had assays as research re IL-1. seems to be having patent disputes re: Il-1 The HYSQ news item deals with a novel IL-1 receptor antagonist. This is not IL-1 that CIST above is having problems with Looking around on Yahoo boards(yeah I admit it, unpure) points to an oppenheimer conference that HYSQ is presenting in next week More DD to be done Pierre